STOCK TITAN
  1. Home
  2. SEC Filings
  3. HLN
  4. [6-K] Haleon plc Current Report (Foreign Issuer)

Haleon buys back 12.6M shares on November 2–6

After settlement, Haleon reported 8,779,531,493 ordinary shares with voting rights.

Available on EDGAR Accepted by SEC EDGAR
Filing Impact
(Moderate)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
6-K

Rhea-AI Filing Summary

Haleon plc (HLN) purchased 12,572,956 ordinary shares of £0.01 each under its share buyback programme announced October 29, 2026, for holding as treasury shares. Purchases took place on the London Stock Exchange from November 2 through November 6, 2026; daily volume-weighted average prices were 320.44p, 327.46p, 331.15p, 340.46p and 333.28p per share, respectively.

After settlement, 28,809,916 shares were held as treasury shares. Haleon reported registered share capital of 8,808,341,409 ordinary shares and 8,779,531,493 ordinary shares with voting rights.

Ordinary shares purchased 12,572,956 shares Share buyback programme; November 2–6, 2026
Volume weighted average price 320.44p per share Purchases on November 2, 2026
Volume weighted average price 327.46p per share Purchases on November 3, 2026
Volume weighted average price 331.15p per share Purchases on November 4, 2026
Volume weighted average price 340.46p per share Purchases on November 5, 2026
Volume weighted average price 333.28p per share Purchases on November 6, 2026
Ordinary shares with voting rights 8,779,531,493 shares Following settlement of the purchases
share buyback programme financial
"under its share buyback programme"
A share buyback programme is when a company uses its cash to purchase its own shares from the market, reducing the number of shares available to other investors; imagine a bakery buying back coupons so fewer are circulating. It matters because cutting the share count can boost earnings per share and increase each remaining investor’s ownership stake, and it also signals management’s view of the stock while using cash that could have been spent on other priorities.
treasury shares financial
"to be held as treasury shares"
Treasury shares are a company’s own stock that it has repurchased and keeps on its books instead of canceling or leaving in the hands of outside investors. Think of them like coupons a business puts back in a drawer: they don’t vote or receive dividends while held, but they can be reissued later for employee pay or fundraising. For investors this matters because buybacks change the number of shares that count toward earnings and ownership, can boost per‑share metrics, and use corporate cash that might otherwise go to growth or dividends.
Volume weighted average price paid per Share financial
"Volume weighted average price paid per Share (p)"
registered share capital financial
"the Company's registered share capital"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many shares did Haleon (HLN) buy back?
Haleon purchased 12,572,956 ordinary shares under its share buyback programme, to be held as treasury shares. The purchases took place from November 2 through November 6, 2026.

What were Haleon (HLN)'s daily average buyback prices?
The volume-weighted average prices were 320.44p on November 2, 327.46p on November 3, 331.15p on November 4, 340.46p on November 5, and 333.28p on November 6, 2026, per share.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 6-K: How Foreign Companies Report to the SEC →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

UNITED STATES
 
SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
For the month of November 2026
 
Commission File Number: 001-41411
 
Haleon plc
(Translation of registrant’s name into English)
 
Building 5, First Floor, The Heights,
Weybridge, Surrey, KT13 0NY
(Address of principal executive offices)
 
 
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
 
 
Form 20-F ☒
 
Form 40-F ☐
 
 
 
EXHIBIT INDEX
 
Exhibit Number
Description
99.1
09 November 2026 - “Transactions in Own Shares”
 
 
 
 
99.1
 
 
Haleon plc: Aggregated information - transactions in own shares
 
09 November 2026: Haleon plc (the “Company” or “Haleon”) today announces the purchase of 12,572,956 ordinary shares of £0.01 each in the Company (the “Shares”) to be held as treasury shares under its share buyback programme announced on 29 October 2026.
 
 
London Stock Exchange
 
CBOE (UK)/BXE
 
CBOE (UK)/CXE
 
Aquis
 
Date of purchase:
 
02 November 2026
 
Number of Shares purchased:
 
2,612,966
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
323.20p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
316.20p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
320.44p
 
-
 
-
 
-
 
Date of purchase:
 
03 November 2026
 
Number of Shares purchased:
 
2,649,689
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
330.00p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
324.30p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
327.46p
 
-
 
-
 
-
 
Date of purchase:
 
04 November 2026
 
Number of Shares purchased:
 
2,010,923
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
338.60p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
321.60p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
331.15p
 
-
 
-
 
-
 
Date of purchase:
 
05 November 2026
 
Number of Shares purchased:
 
2,318,478
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
343.90p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
335.00p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
340.46p
 
-
 
-
 
-
 
Date of purchase:
 
06 November 2026
 
Number of Shares purchased:
 
2,980,900
 
-
 
-
 
-
 
Highest price paid per Share (p):
 
338.60p
 
-
 
-
 
-
 
Lowest price paid per Share (p):
 
329.10p
 
-
 
-
 
-
 
Volume weighted average price paid per Share (p):
 
333.28p
 
-
 
-
 
-
 
 
 
Following the settlement of the above, the Company's registered share capital is 8,808,341,409 ordinary shares of £0.01 each, of which 28,809,916 are held as treasury shares. Therefore, the number of ordinary shares with voting rights is 8,779,531,493 and this figure may be used by shareholders to determine if they are required to notify their interest, or a change to their interest, in Haleon under the FCA's Disclosure Guidance and Transparency Rules.
 
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 as it applies in the UK (the Market Abuse Regulation), a full breakdown of the individual trades is available at the link below:
 
http://www.rns-pdf.londonstockexchange.com/rns/2382C_1-2026-11-6.pdf
 
This announcement does not constitute, or form part of, an offer or any solicitation of an offer for securities in any jurisdiction.
 
This announcement and individual trade breakdown will also be available on the Company's website at: www.haleon.com/investors.
 
Enquiries
 
 
Investors
Media
 
Jo Russell  
+44 7787 392441
Zoë Bird
+44 7736 746167
Rakesh Patel     
+44 7552 484646
Victoria Durman
+44 7894 505730
Email: investor-relations@haleon.com
Email: corporate.media@haleon.com
 
About Haleon
Haleon (LSE/NYSE: HLN) is a consumer company that is solely focused on better everyday health. Our people, our brands, our research, our investment and our innovation are aimed at improving the everyday health of consumers. Our product portfolio spans six major categories - Oral Health, Vitamins, Minerals and Supplements (VMS), Pain Relief, Respiratory Health, Digestive Health and Therapeutic Skin Health and Other. Our superior brands - such as Advil, Centrum, Otrivin, Panadol, parodontax, Polident, Sensodyne, Theraflu and Voltaren – are trusted by more than one billion consumers and are recommended by health professionals around the world.
 
For more information, please visit www.haleon.com. 
 

 
SIGNATURE
 
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 
 
 
HALEON PLC
(Registrant)
 
Date: November 09, 2026
By:
/s/ Amanda Mellor
 
 
Name:
Amanda Mellor
 
 
Title:
Company Secretary


Source: View Original Filing on SEC EDGAR

Keep reading

More on HLN

All HLN news

Trending in the feed

EDSA
Edesa Biotech Announces Agreement with KYORIN Pharmaceutical to Develop and Commercialize Paridiprubart in Japan Open the live feed